Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention - KIVIRID

Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention

Authors: Luis Ortega-Paz, Dominick J Angiolillo

Published: 2022-07-21

DOI: 10.1093/eurheartj/ehac369

Source: Full article

Abstract

No abstract found.